E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/19/2004 in the Prospect News PIPE Daily.

New Issue: IR Biosciences completes $1.65 million private placement

By Sheri Kasprzak

Atlanta, Oct. 19 - IR Biosciences Holdings Inc. finished a $1.65 million private placement.

The deal was comprised of 165 units sold at $10,000 per unit. Each unit included 80,000 shares and 80,000 warrants.

The warrants, exercisable for five years, are for one share at $0.50.

Joseph Stephens & Co. Inc. served as placement agent in the deal and received 3.3 million shares.

Based in Scottsdale, Ariz., IR Biosciences is a biotechnology holding company.

Issuer:IR Biosciences Holdings Inc.
Issue:Units of one share and one warrant
Amount:$1.65 million
Shares:165 units, 80,000 shares per unit (total 13.2 million)
Price:$10,000 per unit ($0.125 per share)
Warrants:One warrant for each share
Warrant expiration:Five years
Warrant strike price:$0.50
Placement agent:Joseph Stephens & Co. Inc.
Settlement date:Oct. 13
Announcement date:Oct. 19
Stock price:$0.26 at close Oct. 13

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.